Pregledni rad
PATIENT WITH PEPTIC ULCER DISEASE
NIVES RADOŠEVIĆ QUADRANTI
; Dom zdravlja Primorsko-goranske županije, Rijeka, Hrvatska
INES DIMINIĆ-LISICA
; Sveučilište u Rijeci, Medicinski fakultet, Katedra za obiteljsku medicinu i Zdravstvena ustanova dr. Ines Diminić-Lisica, Rijeka, Hrvatska
NINA BAŠIĆ MARKOVIĆ
; Specijalistička ordinacija obiteljske medicine Nina Bašić Marković, Rijeka, Hrvatska
BRANISLAVA POPOVIĆ
; Sveučilište u Rijeci, Medicinski fakultet, Katedra za obiteljsku medicinu i Specijalistička ordinacija obiteljske medicine Branislava Popović, dr. med., Rijeka, Hrvatska
Sažetak
Peptic ulcer disease is represented by a lesion in the mucosa of the digestive tract due to imbalance of its aggressive and protective
mechanisms. The main external factors of the development of peptic ulcers are Helicobacter pylori infection and the use of non-steroidal anti infl ammatory drugs (NSAIDs) and acetylsalicylic acid (ASA). Symptoms of peptic ulcer disease are a common reason for visiting the family physician. All patients with symptoms of dyspepsia under the age of 50 and without the alarm symptoms should be tested whether H. pylori is present by performing the Urea Breath Test or stool antigene testing, and infection, if found, should be treated. Endoscopic examination is obligatory in patients older than 50 years and those with alarm symptoms. „Sequential therapy“ is recommended in Croatia as the fi rst-line treatment of H. pylori infection, or triple therapy that comprises applying a proton pump inhibitor (PPI) in combination with amoxicillin and metronidazole. Four weeks after eradication therapythe control testing for H. pylori should be performed.
Ključne riječi
peptic ulcer; Helicobacter pylori; eradication therapy; dyspepsia
Hrčak ID:
154155
URI
Datum izdavanja:
12.3.2016.
Posjeta: 3.527 *